(Q73369641)

English

Reumacon (CPH82) showed similar x‐ray progression and clinical effects as methotrexate in a two year comparative study on patients with early rheumatoid arthritis

scientific article published on 01 January 2003

In more languages
default for all languages
No label defined

No description defined

Statements

Reumacon (CPH82) showed similar x-ray progression and clinical effects as methotrexate in a two year comparative study on patients with early rheumatoid arthritis (English)
Reumacon (CPH82) showed similar x‐ray progression and clinical effects as methotrexate in a two year comparative study on patients with early rheumatoid arthritis (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit